Navigation Links
ALTO-8 (Bench top Version) from ABgene

ProductsALTO-8 (Bench top Version) from ABgene
Company ABgene
Item ALTO-8 (Bench top Version)
Price 
Description Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes.
Info ABgeneABgene
ABgene House
Blenheim Road
Epsom
Surrey KT19 9AP
UK
Customer Service: +44 (0)1372 723456
Fax Number: +44 (0)1372 741414
Web Site: http://www.abgene.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. ALTO-8 (Integration friendly version) from ABgene
2. In Vivo Perfusion System (Rat Version) from AutoMate Scientific, Inc
3. 1-D PAGE Cleavable ICAT Reagent Applications Development Kit for Targeted Protein ID and Quantitation (monoplex Version) from Applied Biosystems
4. ABsolute QRT-PCR SYBR Green Fluorescein Mix from ABgene
5. Reverse-iT One-Step Kit, ReddyMix from ABgene
6. Thermo-Fast 96 PCR Plate, Non-Skirted from ABgene
7. ABsolute QPCR SYBR Green ROX Mix from ABgene
8. Workstation/Stacking System from ABgene
9. Extensor Hi-Fidelity PCR Enzyme from ABgene
10. SmartScan Solo from ABgene
11. Smart Scan 96 from ABgene
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
3M Imidazole Solution 125 ml...
PFM8 Antibody...
Goat polyclonal to DDDDK tag (FITC) ( Abpromise for all tested applications)....
Biology Products:
(Date:12/4/2009)... Dr. Daniel Leskovar, a Texas AgriLife Research plant ... in Uvalde, has been investigating ways to help vegetable ... to the field. , "This research can aid in ... of some vegetable crops by producing high-quality, more adaptive ...
(Date:12/4/2009)... widely used by physicians and scientists to study brain ... remained largely unknown whether the electrodes on the head ... the brain. Scientists at the Max Planck Institute for ... crucial link between the activity generated within the brain ...
(Date:12/3/2009)... 3 BIO-key International, Inc. (OTC Bulletin Board: ... finger-based biometric identification solutions, announced that a majority ... held today approved the sale of the company,s ... Of the shares voted, 98.6% were cast in ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How to read brain activity? 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 1Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 2The Power of Five 3A New OmniFlex Nourishes Joints in Convenient Effective Doses 56112 1The Power of Five 3A New OmniFlex Nourishes Joints in Convenient Effective Doses 56112 2Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 1Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 2Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 3
... trees -- some are short and bushy with many branches ... of one or two main trunks. Different branching patterns correlate ... these dissimilar patterns come about and why. , A new ... University of New Jersey, examines the role of the protein ...
... gene expression in the brain can differ significantly among ... study indicates that roughly 15 percent of Atlantic salmon ... their freshwater birthplaces to mature in oceans versus those ... , The researchers, at Harvard University, the University of ...
... biological trigger that gives rise to Van Buchem ... cause blindness and deafness. The findings provide insight ... new treatments for osteoporosis and other crippling bone ... and Lawrence Berkeley national laboratories, the Novartis Institutes ...
Other Biology News:Snapin: A protein with therapy potential for autism 2Divergent life history shapes gene expression in brains of salmon 2Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ... previously announced unit offering, the underwriters have exercised in ... units. Each unit is comprised of one common share ... was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)... today announced data presentations on its novel oral JAK2 ... Annual Meeting and Exposition in New Orleans. ,, Data ... Phase 1 dose-escalation trial of SB1518 detailing its safety, ... from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)... The Scientist, a leading scientific magazine covering the life sciences, ... “Top 10 Innovations of 2009. , ... ... EMCCD camera from Photometrics ®, a designer and ...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3